BIBvsJDOC
ProShares Ultra Nasdaq Biotechnology against JPMorgan Healthcare Leaders ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| BIB | JDOC | |
|---|---|---|
| Expense ratio | 0.95% | 0.65% |
| Assets | $93M | $9048.54T |
| Net flow, 1 month | −$3M | — |
| Net flow, 1 year | −$11M | −$25K |
| Return, YTD | +37.6% | +2.9% |
| Return, 1 year | +73.2% | +10.6% |
| Avg daily volume | 8K | 241 |
| Holdings | 229 | 67 |
| Listed | Apr 9, 2010 | Oct 31, 2023 |
| Options market | Yes | No |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS